Macrophages can alternate between two states: an inflammatory state for fighting infection and a non-inflammatory state for ...

Scientists at the University of Oxford, have identified how rare populations of abnormal cells drive the formation and ...

Ontunisertib could become the first FDA-approved anti-fibrotic suitable for Crohn’s disease patients with symptomatic ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment -- -- Pharmacokinetic results confirm gut-restricted profile of ontunisertib in FSCD patients -- -- ...

UChicago Medicine has opened the first clinic of its kind in Chicago, and one of only a few nationwide, focused on preconception and pregnancy care for patients with Crohn’s disease and ulcerative ...

UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...

Thanks to COVID-era discussions, the 2023 coverage of a Delta passenger who had diarrhea in their seat (I cannot imagine), ...

Learn about the connection between Crohn’s disease and night sweats, their possible causes, and get practical tips from ...

Proactive care and early treatment help prevent serious IBD complications and improve patients’ quality of life.

The TL1a inhibitor duvakitug was effective at 14 weeks in patients who had previous exposure to conventional and advanced ...

Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...